Bayer CropScience Ltd reports inter‑promoter transfer of 5.35 million shares (11.91% stake) to Bayer AG

What Bayer CropScience Ltd announced

Bayer CropScience Ltd filed a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, informing the market of an inter‑promoter transfer of equity shares. On July 8, 2026, Bayer CropScience AG, a promoter of the target company, sold 5,354,030 equity shares to Bayer AG, another promoter, through a block‑deal mechanism. The transaction was reported to the Bombay Stock Exchange on July 10, 2026.

"This is to inform you that Bayer CropScience AG, a promoter of the Target Company has sold 53,54,030 equity shares to Bayer AG, another promoter of the Target Company, pursuant to the block deal mechanism on July 8, 2026."

The filing confirms that the transfer does not involve any external party and is purely an intra‑group reshuffling of shareholding.

Details of the inter‑promoter transfer

• Number of shares transferred: 5,354,030 equity shares (face value INR 10 each).
• Percentage of diluted voting capital: 11.91%.
• Monetary value: INR 4,49,42,092 (approximately Rs 449.42 million), calculated on the basis of the face value of the shares.
• Mode of acquisition: Inter‑se transfer via block‑deal, i.e., a single‑day, off‑exchange transaction executed at a pre‑determined price.
• Date of transaction: July 8, 2026.
• Date of filing: July 10, 2026 (09:50:56 UTC).
• Promoter status: Both the seller (Bayer CropScience AG) and the acquirer (Bayer AG) are promoters of Bayer CropScience Ltd.
• Persons Acting in Concert (PAC): Bayer AG, Bayer SAS, Monsanto Company, Bayer Vapi Private Limited, and Bayer Investments India Private Limited.

The filing also provides a snapshot of the shareholding structure before and after the transaction, indicating that the transferred shares were not encumbered and no voting rights were held through other instruments such as warrants or convertible securities.

Persons Acting in Concert and promoter group

The disclosure lists five entities that are considered Persons Acting in Concert (PAC) with the acquirer:

1. Bayer AG – the direct acquirer of the shares.
2. Bayer SAS – a subsidiary of the Bayer Group.
3. Monsanto Company – part of the Bayer corporate family.
4. Bayer Vapi Private Limited – an Indian private limited company under the Bayer umbrella.
5. Bayer Investments India Private Limited – another Indian investment vehicle of Bayer.

All these entities are part of the broader Bayer promoter group, confirming that the share transfer is an internal consolidation rather than an external acquisition. The filing explicitly states, "Yes, the Acquirer is a promoter of the Target Company."

Key facts at a glance

Why this matters for investors

The disclosure is a compliance requirement under SEBI’s takeover regulations, which aim to keep the market informed of any substantial change in shareholding, especially when promoters are involved. For shareholders, the key implications are:

• No dilution: The transfer is between promoters, so the total number of shares outstanding remains unchanged. Existing shareholders’ proportional ownership is unaffected.
• Transparency of promoter holdings: By reporting the transaction, the company provides clarity on the concentration of promoter control. After the transfer, the combined promoter group holds an additional 11.91% of the diluted voting capital, consolidating their influence.
• Regulatory compliance: The filing satisfies the statutory obligation to disclose any acquisition or disposal that crosses the 1% threshold of voting capital, ensuring that the market remains aware of material share‑holding changes.
• Potential future actions: While the current move is an internal reshuffle, it may signal the promoter group’s intent to streamline ownership or prepare for future strategic actions. However, the filing does not disclose any such plans.

Investors should note that the transaction does not involve cash flow to the company, nor does it affect the company’s balance sheet directly. The primary relevance lies in the governance aspect and the visibility of promoter concentration.

Conclusion

Bayer CropScience Ltd has disclosed an inter‑promoter transfer of 5.35 million shares, amounting to 11.91% of its diluted voting capital, executed on July 8, 2026 and reported on July 10, 2026. The transaction consolidates promoter holdings without altering the total share count or diluting existing shareholders. The filing fulfills SEBI’s Regulation 29(2) requirements, providing the market with transparent information on promoter share movements. No further regulatory approvals are pending for this specific transfer.